Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay P McLaughlin

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Neuroimmune Pharmacology and Therapeutics|May 7, 2024
SRI-30827, a novel allosteric modulator of the dopamine transporter, alleviates HIV-1 Tat-induced potentiation of cocaine conditioned place preference in miceHaylee R Hammond, Shainnel O Eans, Thomas J Cirino, et al.
Neuroimmune Pharmacology and Therapeutics|February 17, 2025
Something to talk about; crosstalk disruption at the neurovascular unit during HIV infection of the CNSKalpani N Udeni Galpayage Dona, Mohammed M Benmassaoud, Cassandra D Gipson, et al.
Organic & Biomolecular Chemistry|May 17, 2019
Antinociceptive activity of thiazole-containing cyclized DAMGO and Leu-(Met) enkephalin analogsHannah M Harris, Shainnel O Eans, Michelle L Ganno, et al.
Geroscience|April 5, 2021
In vivo proton magnetic resonance spectroscopy detection of metabolite abnormalities in aged Tat-transgenic mouse brainJason J Paris, Xi Chen, Joseph Anderson, et al.
Molecules (Basel, Switzerland)|February 25, 2023
Solid-Phase Synthesis of the Bicyclic Peptide OL-CTOP Containing Two Disulfide Bridges, and an Assessment of Its In Vivo μ-Opioid Receptor Antagonism after Nasal AdministrationRamanjaneyulu Rayala, Annika Tiller, Shahayra A Majumder, et al.
Glia|May 8, 2018
HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specificDouglas R Miller, Fatemeh Shaerzadeh, Leah Phan, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 29, 2020
[<sup>3</sup>H]Dopamine Uptake through the Dopamine and Norepinephrine Transporters is Decreased in the Prefrontal Cortex of Transgenic Mice Expressing HIV-1 Transactivator of Transcription ProteinMatthew Strauss, Bernadette O'Donovan, Yizhi Ma, et al.
British Journal of Pharmacology|February 22, 2013
The macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administrationShainnel O Eans, Michelle L Ganno, Kate J Reilley, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 16, 2013
Physical presence of nor-binaltorphimine in mouse brain over 21 days after a single administration corresponds to its long-lasting antagonistic effect on κ-opioid receptorsKshitij A Patkar, Jinhua Wu, Michelle L Ganno, et al.
Journal of Medicinal Chemistry|October 1, 2014
Nonpeptide small molecule agonist and antagonist original leads for neuropeptide FF1 and FF2 receptorsV Blair Journigan, Christophe Mésangeau, Neha Vyas, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Neuroimmune Pharmacology and Therapeutics|May 7, 2024
SRI-30827, a novel allosteric modulator of the dopamine transporter, alleviates HIV-1 Tat-induced potentiation of cocaine conditioned place preference in miceHaylee R Hammond, Shainnel O Eans, Thomas J Cirino, et al.
Neuroimmune Pharmacology and Therapeutics|February 17, 2025
Something to talk about; crosstalk disruption at the neurovascular unit during HIV infection of the CNSKalpani N Udeni Galpayage Dona, Mohammed M Benmassaoud, Cassandra D Gipson, et al.
Organic & Biomolecular Chemistry|May 17, 2019
Antinociceptive activity of thiazole-containing cyclized DAMGO and Leu-(Met) enkephalin analogsHannah M Harris, Shainnel O Eans, Michelle L Ganno, et al.
Geroscience|April 5, 2021
In vivo proton magnetic resonance spectroscopy detection of metabolite abnormalities in aged Tat-transgenic mouse brainJason J Paris, Xi Chen, Joseph Anderson, et al.
Molecules (Basel, Switzerland)|February 25, 2023
Solid-Phase Synthesis of the Bicyclic Peptide OL-CTOP Containing Two Disulfide Bridges, and an Assessment of Its In Vivo μ-Opioid Receptor Antagonism after Nasal AdministrationRamanjaneyulu Rayala, Annika Tiller, Shahayra A Majumder, et al.
Glia|May 8, 2018
HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specificDouglas R Miller, Fatemeh Shaerzadeh, Leah Phan, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 29, 2020
[<sup>3</sup>H]Dopamine Uptake through the Dopamine and Norepinephrine Transporters is Decreased in the Prefrontal Cortex of Transgenic Mice Expressing HIV-1 Transactivator of Transcription ProteinMatthew Strauss, Bernadette O'Donovan, Yizhi Ma, et al.
British Journal of Pharmacology|February 22, 2013
The macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administrationShainnel O Eans, Michelle L Ganno, Kate J Reilley, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 16, 2013
Physical presence of nor-binaltorphimine in mouse brain over 21 days after a single administration corresponds to its long-lasting antagonistic effect on κ-opioid receptorsKshitij A Patkar, Jinhua Wu, Michelle L Ganno, et al.
Journal of Medicinal Chemistry|October 1, 2014
Nonpeptide small molecule agonist and antagonist original leads for neuropeptide FF1 and FF2 receptorsV Blair Journigan, Christophe Mésangeau, Neha Vyas, et al.
Pageof 11